Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic
12
0
2
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
8.3%
1 terminated/withdrawn out of 12 trials
85.7%
-0.8% vs industry average
8%
1 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (12)
Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB
Role: collaborator
A Longitudinal Cohort Study to Evaluate Cardiovascular Risk Factors and Disease in Haiti
Role: collaborator
Treatment of Early Hypertension Among Persons Living With HIV in Haiti
Role: collaborator
FANMI: Community Cohort Care for HIV-Infected Adolescent Girls in Haiti
Role: collaborator
A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIV
Role: collaborator
Immediate Fast-Track Versus Standard Care for Persons Living With HIV in Haiti
Role: collaborator
Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults
Role: lead
Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD
Role: lead
Point-of-care Viral Load Testing Among HIV-infected Adolescents in Haiti
Role: collaborator
Same-Day Treatment With Genvoya vs. EFV/TDF/3TC
Role: lead
Same-Day HIV Testing and Treatment Initiation to Improve Retention in Care
Role: collaborator
Evaluation of an Infant Feeding Intervention for HIV-exposed Haitian Infants
Role: collaborator
All 12 trials loaded